UA109259C2 - METHODS AND COMPOSITIONS FOR THE TREATMENT OF MEDICAL STATES CONNECTED WITH THE THYROID, WITH THE aid of RESTORED FLATS - Google Patents

METHODS AND COMPOSITIONS FOR THE TREATMENT OF MEDICAL STATES CONNECTED WITH THE THYROID, WITH THE aid of RESTORED FLATS

Info

Publication number
UA109259C2
UA109259C2 UAA201201434A UAA201201434A UA109259C2 UA 109259 C2 UA109259 C2 UA 109259C2 UA A201201434 A UAA201201434 A UA A201201434A UA A201201434 A UAA201201434 A UA A201201434A UA 109259 C2 UA109259 C2 UA 109259C2
Authority
UA
Ukraine
Prior art keywords
treatment
thyroid
folate
flats
restored
Prior art date
Application number
UAA201201434A
Other languages
Russian (ru)
Ukrainian (uk)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2010/041631 external-priority patent/WO2011006147A1/en
Application filed filed Critical
Publication of UA109259C2 publication Critical patent/UA109259C2/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Винахід стосується застосування композиції, яка містить фолат, для лікування або попередження зниженого вмісту фолату в спинномозковій рідині у індивідуума з гіпотиреозом, який приймає лікарські препарати для лікування станів щитоподібної залози. Крім того, винахід стосується застосування композиції, яка містить лікарський засіб, що стимулює щитовидну залозу, агент, лікарський препарат або гормон, який виконує функцію гормону, що звичайно виробляється щитоподібною залозою, фолат і вітамін В12 для лікування або попередження зниженого вмісту фолату у спинномозковій рідині у індивідуума з гіпотиреозом, який приймає лікарські препарати для лікування станів щитоподібної залози.The invention relates to the use of a composition containing folate for the treatment or prevention of low levels of folate in cerebrospinal fluid in an individual with hypothyroidism who is taking drugs for the treatment of conditions of the thyroid gland. The invention also relates to the use of a composition comprising a thyroid stimulating drug, an agent, a drug or a hormone that normally acts as a thyroid hormone, folate and vitamin B12 for the treatment or prevention of low folate levels in the spinal cord in an individual with hypothyroidism who is taking medication to treat a condition of the thyroid gland.

UAA201201434A 2009-07-10 2010-09-07 METHODS AND COMPOSITIONS FOR THE TREATMENT OF MEDICAL STATES CONNECTED WITH THE THYROID, WITH THE aid of RESTORED FLATS UA109259C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27061509P 2009-07-10 2009-07-10
PCT/US2010/041631 WO2011006147A1 (en) 2009-07-10 2010-07-09 Methods and compositions for treating thyroid-related medical conditions with reduced folates

Publications (1)

Publication Number Publication Date
UA109259C2 true UA109259C2 (en) 2015-08-10

Family

ID=54771602

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201201434A UA109259C2 (en) 2009-07-10 2010-09-07 METHODS AND COMPOSITIONS FOR THE TREATMENT OF MEDICAL STATES CONNECTED WITH THE THYROID, WITH THE aid of RESTORED FLATS

Country Status (1)

Country Link
UA (1) UA109259C2 (en)

Similar Documents

Publication Publication Date Title
PH12013501790B1 (en) Use of dpp iv inhibitors
UA109878C2 (en) Isoquinolinone derivatives, pharmaceutical composition based on them (variants), and method of treating diseases (variants)
GB2491328A (en) Immediate/delayed drug delivery
BR112013018920A2 (en) nanoparticle compositions, formulations thereof and their uses
PH12014501560A1 (en) Carbamate compounds and of making and using same
BR112015026006A2 (en) methods for treating cancer with the use of tor kinase inhibitor combination therapy
MX2022003072A (en) Use of pridopidine for treating functional decline.
GB2467670A (en) Chemical entities and therapeutic uses thereof
UA101309C2 (en) Activin-actrii antagonists thereof and uses for increasing red blood cell levels
BRPI0516718B8 (en) modified release formulation of ibuprofen providing immediate and prolonged release of the drug
MX2013013809A (en) Expandable devices coated with a paclitaxel composition.
MX2009011898A (en) Compositions and methods for treating disorders associated with salt or fluid retention.
PE20142319A1 (en) MULTIPLE SCLEROSIS TREATMENT WITH A COMBINATION OF LAQUINIMOD AND GLATIRAMER ACETATE
MX2013007189A (en) Methods and compositions suitable for managing blood glucose in animals.
IN2015DN03219A (en)
AR089862A1 (en) USE OF LAQUINIMOD FOR THE TREATMENT OF PATIENTS WITH CROHN'S DISEASE IN THOSE WHO FAILS AN ANTI-FACTOR THUMOR NECROSIS THERAPY a (ANTI-TNFa) FIRST LINE
MX352824B (en) USE OF LEVOCETIRIZINE and MONTELUKAST IN THE TREATMENT OF INFLUENZA, COMMON COLD and INFLAMMATION.
MX2017004772A (en) Compositions and methods for physiological delivery using cannabidiol.
MX2012000275A (en) Acid pump antagonist for treatment of diseases associated with abnormal gastrointestinal movement.
BR112012030641A2 (en) methods and compositions for oral pharmaceutical therapy
PH12016500140A1 (en) Heterobicycloaryl rorc2 inhibitors and methods of use thereof
EA201270226A1 (en) VITAMIN D3 AND HIS ANALOGY FOR THE TREATMENT OF ALOPECIA
BR112015004110A2 (en) prostate drug delivery systems and methods
BR112015003836A2 (en) drug delivery systems and methods for bladder cancer treatment
NZ598171A (en) Methods and compositions for treating thyroid-related medical conditions with reduced folates